Ulrich Schüller

University Medical Center Hamburg-Eppendorf

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Robin Khatri

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Franz L Ricklefs

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Lina Bergmann

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Christopher Lazarski

Assistant Professor

George Washington University

UNITED STATES

View details

Malik Alawi

Head

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Koichi Ichimura

Specially Appointed Professor

Juntendo University

JAPAN

View details

Jakob Matschke

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Julia E. Neumann

Prof. Dr. med.

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Patrick N. Harter

Professor for molecular Neuropathology

Ludwig Maximilian University of Munich

GERMANY

View details

Sergey A. Dyshlovoy

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Rudolph Reimer

Head of Electron Microscopy

Leibniz-Institut für Experimentelle Virologie

GERMANY

View details

Stefan Bonn

Professor, Institute Director

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ulrich Schüller

Research Interests

Explore related searches

Contact this professor

Articles (20)

Peripheral blood‐derived immune cell counts as prognostic indicators and their relationship with DNA methylation subclasses in glioblastoma patients

Integration of omics data in the diagnosis and therapy of glioblastoma

Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-model

Applications of Nanopore sequencing in precision cancer medicine

Morphology‐based molecular classification of spinal cord ependymomas using deep neural networks

Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients

40‐Year‐old man with two asynchronous spinal cord tumors

Specifics of spinal neuropathology in the molecular age

Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features

Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation

Epigenetic profiling reveals a strong association between lack of 5-ALA fluorescence and EGFR amplification in IDH-wildtype glioblastoma

Adult intracranial ependymoma—relevance of DNA methylation profiling for diagnosis, prognosis, and treatment

Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease

Targeted anticonvulsive treatment of IDH-wildtype glioblastoma based on DNA methylation subclasses

Generation of new transgenic SMARCA4‐deficient mouse models results in neuromuscular weakness and paralysis of limbs

DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients

Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification

DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients

OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma

Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond

Collaborators (12)

Robin Khatri

Franz L Ricklefs

Lina Bergmann

Christopher Lazarski

Malik Alawi

Koichi Ichimura

Jakob Matschke

Julia E. Neumann

Patrick N. Harter

Sergey A. Dyshlovoy

Rudolph Reimer

Stefan Bonn

Make your next move.